These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1203875)

  • 21. Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer.
    Smith BL; Bertagnolli M; Klein BB; Batter S; Chang M; Douville LM; Eberlein TJ
    Ann Surg; 1992 Jul; 216(1):17-21. PubMed ID: 1321595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
    Bauer TL; Pandelidis SM; Rhoads JE
    J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study.
    Tweedie E; Tonkin K; Kerkvliet N; Doig GS; Sparrow RK; O'Malley FP
    Clin Invest Med; 1997 Oct; 20(5):300-7. PubMed ID: 9336655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
    Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
    Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special lecture: the breast cancer screening controversy: a perspective.
    Moskowitz M; Gartside P; Gardella L; de Groot I; Guenther D
    AJR Am J Roentgenol; 1977 Sep; 129(3):537-43. PubMed ID: 409220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathology of breast cancer detected by mass population screening.
    Patchefsky AS; Shaber GS; Schwartz GF; Feig SA; Nerlinger RE
    Cancer; 1977 Oct; 40(4):1659-70. PubMed ID: 907976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of echography and US-guided percutaneous puncture in addition to mammography for the detection of malignant breast tumors].
    Matricardi L; Lovati R; Nazzaro V; Guarneri A; Calzoni G; Gagliano E; Donato F
    Radiol Med; 1992 Apr; 83(4):395-401. PubMed ID: 1318561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.
    Rubin E; Visscher DW; Alexander RW; Urist MM; Maddox WA
    Cancer; 1988 May; 61(10):2077-82. PubMed ID: 3359405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer survival among women under age 50: is mammography detrimental?
    Stacey-Clear A; McCarthy KA; Hall DA; Pile-Spellman E; White G; Hulka C; Whitman GJ; Mahoney E; Kopans DB
    Lancet; 1992 Oct; 340(8826):991-4. PubMed ID: 1357448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful first round results of a Turkish breast cancer screening program with mammography in Bahcesehir, Istanbul.
    Kayhan A; Gurdal SO; Ozaydin N; Cabioglu N; Ozturk E; Ozcinar B; Aribal E; Ozmen V
    Asian Pac J Cancer Prev; 2014; 15(4):1693-7. PubMed ID: 24641392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
    Miller AB; To T; Baines CJ; Wall C
    J Natl Cancer Inst; 2000 Sep; 92(18):1490-9. PubMed ID: 10995804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of localized breast cancer by prospective mammographic screening criteria.
    Knaus JV; Dolan JR; Isaacs JH
    Am J Obstet Gynecol; 1988 Jan; 158(1):147-9. PubMed ID: 2827485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mammography and ultrasound in the diagnosis of clinically occult breast cancer].
    Gyr T; Almendral AC; Meier D
    Gynakol Rundsch; 1989; 29(2):65-8. PubMed ID: 2544492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult lesions of the breast.
    Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
    Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project.
    Lopez MJ; Smart CR
    Surg Oncol Clin N Am; 1997 Apr; 6(2):393-401. PubMed ID: 9115504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnification views of mammography decrease biopsy rates.
    Madan AK; Nguyen MT; Wakabayashi MN; Beech DJ
    Am Surg; 2001 Jul; 67(7):687-9. PubMed ID: 11450790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.